Get started
Author

Jun Hanaoka

ORCID: 0009-0001-0851-8192
Observed ORCID: 0009-0001-0851-8192
OpenAlex ID: A5115979988
Dynamic changes in the characteristics of hepatocellular carcinoma among Japanese patients: Increasing incidence of cases without liver fibrosis
2025 · Fujimasa Tada, Atsushi Hiraoka, et al. · Hepatology Research · 4
PDF
Prognostic Stratification of Initial Treatments for Hepatocellular Carcinoma Using a Modified Borderline Resectable Classification
2025 · Fujimasa Tada, Atsushi Hiraoka, et al. · Cancer Medicine · 1
PDF
Impact of TOPAZ-1 eligibility on the survival benefit of durvalumab plus gemcitabine–cisplatin in advanced biliary tract cancer: a multicenter real-world study
2026 · Hisashi Kosaka, Rie Sugimoto, et al. · Journal of Gastroenterology
PDF
Survival Outcomes of Gemcitabine–Cisplatin–S‐1 Versus Gemcitabine–Cisplatin in Unresectable Biliary Tract Cancer: A Multicenter Retrospective Study With a Focus on Conversion Surgery
2026 · Hisashi Kosaka, Masahiko Kinoshita, et al. · Annals of Gastroenterological Surgery
PDF
Malignant biliary obstruction treated with preoperative endoscopic ultrasound-guided hepaticogastrostomy: A case report
2025 · Taira Kuroda, Hideki Miyata, et al. · International Journal of Gastrointestinal Intervention
Works count: 5
Citation count: 5
H-index: 1
I10-index:
Year
Topic
Type